Mogamulizumab (Anti-CCR4 / CD194)
Catalogue Number: A2568-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Alias: | KW-0761 |
| Shipping Condition: | Dry Ice |
| Unit(s): | 1 mg, 5 x 1 mg, 25 x 1 mg |
| Host name: | |
| Clone: | |
| Isotype: | |
| Immunogen: |
Additional Text
CAS Number
1159266-37-1
Short Description
Mogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.
Storage Note
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
A2568 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations